Ilika’s defence testing opens a new angle on solid-state battery value

Ilika Plc

Ilika’s latest update adds a different dimension to the investment case around its solid-state battery technology. Rather than focusing solely on future automotive or industrial uses, the company has highlighted how its large-format Goliath cells performed in defence-related testing designed to reflect battlefield conditions.

The key point from the testing is that a 10Ah Goliath cell was able to withstand an initial ballistic impact, with a thermal event only taking place after a second shot Battery developers often face a long path from laboratory promise to commercial credibility, particularly when safety is part of the core sales argument. Evidence that a cell can tolerate severe physical abuse without an immediate worst-case outcome may help support Ilika’s claim that solid-state chemistry can offer a more resilient safety profile in environments where failure tolerance is critical.

Any application where batteries are exposed to physical stress, operational uncertainty or strict safety thresholds could benefit from validation of this kind. Demonstrating a measured response under impact could therefore improve Ilika’s commercial conversation in sectors where risk management carries as much weight as raw battery capability.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Defence battery demand highlights strategic opening for Ilika

Ilika highlights how rising defence and energy security demands are expanding the commercial opportunity for advanced battery technologies across military and infrastructure markets.

Ilika to showcase Stereax batteries to medical device manufacturers

Ilika’s Stereax batteries will be represented at Medical Technology Ireland 2026, giving the company direct exposure to medical device manufacturers and suppliers.

Ilika puts Stereax in front of medical device buyers

Ilika’s Stereax batteries will be represented at MEDevice Silicon Valley, putting the technology in front of medical device buyers and engineers.

Ilika to present solid-state battery progress at major UK energy storage conference

Ilika will present its Goliath quasi-solid-state cell technology at the Faraday Institution Conference 2026, giving investors a clear positioning update.

Search